Fluicell AB (FRA:5J90) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5J90 Fluicell AB FRA:5J90
61 GF Score
Price €2.93
GF Value €2.88
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fluicell AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:5J90 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Fluicell AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fluicell AB Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fluicell AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Fluicell AB's Short Interest falls into.


FRA:5J90
61GF Score
Fluicell AB FRA:5J90
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fluicell AB (FRA:5J90) Overvalued in 2026?

Based on GuruFocus' analysis, Fluicell AB stock appears to be overvalued. The current stock price of €2.93 is trading 1.7% above its estimated GF Value™ of €2.88. GuruFocus considers Fluicell AB to be Fairly Valued.

Key valuation signals for FRA:5J90:

  • Short Interest:
  • GF Value™: €2.88 vs. price of €2.93 (1.7% above fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the FRA:5J90 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fluicell AB Business Description

Other Exchanges FLUI:Sweden
Address Flojelbergsgatan 8C, Molndal, Gothenburg, SWE, 431 37
Fluicell AB is a Swedish life science company that conducts development in regenerative medicine and human tissue-based screening models for drug development, with a particular focus on the areas of type 1 diabetes, cardiac safety screening models, and kidney diseases. The company's platform for the production of human tissue that is based on Fluicell's technology for high-resolution 3D bioprinting, and which enables the creation of tissue-based products for use in drug development and regenerative medicine.
61GF Score

Get the complete analysis for FRA:5J90

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.93
Price
€2.88
GF Value